Tips on how to surmount the challenges of working with CRISPR to manipulate genes in human stems cells to study their function in specific diseases or to correct genetic defects in patient cells.

As AI moves from pilots to business-critical deployment, the issue is no longer access. Itʼs trust. Open source tools support that trust by keeping core components inspectable and standardizable, ...

Cell-based assays are popular for high-throughput screens, where they strike a balance between ease of use and similarity to the human body that researchers aim to treat.